News Quantified

JAGX – jaguar health, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication [Yahoo! Finance]

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs [Yahoo! Finance]

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue [Yahoo! Finance]

Jaguar Health, Inc. (JAGX) Q3 2025 Earnings Call Prepared Remarks Transcript [Seeking Alpha]

Jaguar Health outlines dual NDA filing targets for late 2026 as clinical catalysts converge [Seeking Alpha]

Form 8-K/A Jaguar Health, Inc. For: Jan 06

Form 8-K Jaguar Health, Inc. For: Jan 05

Form 8-K Jaguar Health, Inc. For: Jan 12

Form SCHEDULE 13G Jaguar Health, Inc. Filed by: Mailman Joshua

Form 4 Jaguar Health, Inc. For: Dec 11 Filed by: Chaturvedi Pravin R

Top News Gainers

6/11 Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication 35.0%

10/30 Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc. 28.6%

11/12 Jaguar Health to Host Investor Call Nov. 14th at 9 a.m. Eastern Regarding Interim Analysis of HALT-D Study of Mytesi (Crofelemer) for Prevention of Diarrhea in Breast Cancer Patients, Q3 Financials & Business Updates 25.7%

12/31 Jaguar Health Inc (NASDAQ: JAGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 17.8%

9/30 Jaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Application 12.0%

9/12 Jaguar Health Inc (NASDAQ: JAGX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock. 10.8%

8/20 Form 3 Jaguar Health, Inc. For: Aug 13 Filed by: Lizak Carol R. 10.3%

6/24 Jaguar Health Regains Compliance with All Applicable Nasdaq Stock Market Listing Standards 9.5%

9/16 Jaguar Health's Mytesi Drug Product Now Approved for Sale in Puerto Rico 8.3%

12/26 Form 8-K Jaguar Health, Inc. For: Dec 20 6.9%

Top News Decliners

11/14 Jaguar Health Inc (NASDAQ: JAGX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -28.8%

4/16 Form 8-K Jaguar Health, Inc. For: Apr 15 -22.1%

8/14 Form 10-Q Jaguar Health, Inc. For: Jun 30 -20.9%

6/6 Jaguar Health, Inc. Announces 1-for-70 Reverse Stock Split -19.0%

3/23 Form 8-K Jaguar Health, Inc. For: Mar 21 -19.0%

7/5 Form FWP Jaguar Health, Inc. Filed by: Jaguar Health, Inc. -15.1%

9/24 Form 8-K Jaguar Health, Inc. For: Sep 24 -12.9%

5/11 Jaguar Health readies $10M equity offering [Seeking Alpha] -12.6%

7/15 Form S-1/A Jaguar Health, Inc. -12.4%

10/1 Jaguar Health Files Final Canalevia (Crofelemer) Technical Section for Proposed Indication of Chemotherapy-Induced Diarrhea in Dogs -12.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day